AIP
MBX

Ameritas Investment Partners’s MBX Biosciences MBX Stock Holding History

Ameritas Investment Partners’s Portfolio MBX Stock Details MBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$155K Buy
2,817
+505
+22% +$17.6K ﹤0.01% 1561
2026
Q1 		$69K Hold
2,312
– – ﹤0.01% 1896
2025
Q4 		$72.9K Buy
2,312
+1,135
+96% +$27.5K ﹤0.01% 1885
2025
Q3 		$20.6K Hold
1,177
– – ﹤0.01% 2649
2025
Q2 		$13.4K Hold
1,177
– – ﹤0.01% 2851
2025
Q1 		$8.69K Hold
1,177
– – ﹤0.01% 2866
2024
Q4 		$21.7K Buy
+1,177
New +$25.1K ﹤0.01% 2598

Other funds holding MBX

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
NA
NVP Associates Menlo Park, California $328M AUM 166.51% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Ameritas Investment Partners's MBX Position: Q2 2026 in Review

Ameritas Investment Partners increased its MBX Biosciences (MBX) stake by 22% in Q2 2026, buying an estimated $17.6K and bringing the position to 2,817 shares worth $155K. The position accounts for ﹤0.01% of the portfolio, ranked #1561.

Ameritas Investment Partners first reported a position in MBX in Q4 2024 and has held it in 7 quarters since. 173 funds tracked by Wall St. Rank hold MBX as of Q2 2026.

  • Ameritas Investment Partners held 2,817 shares of MBX Biosciences worth $155K as of Q2 2026.
  • Ameritas Investment Partners bought 505 MBX Biosciences shares in Q2 2026, an estimated $17.6K.
  • MBX Biosciences made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #1561 holding.
  • Ameritas Investment Partners first reported a position in MBX Biosciences in Q4 2024 and has held it in 7 quarters since.
  • 173 funds tracked by Wall St. Rank held MBX Biosciences as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.